GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Additional Paid-In Capital

Laurus Labs (BOM:540222) Additional Paid-In Capital : ₹0 Mil(As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Additional Paid-In Capital?


Laurus Labs's annual additional paid-in capital increased from Mar. 2023 (₹7,131 Mil) to Mar. 2024 (₹7,171 Mil) but then declined from Mar. 2024 (₹7,171 Mil) to Mar. 2025 (₹0 Mil).


Laurus Labs Additional Paid-In Capital Historical Data

The historical data trend for Laurus Labs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Additional Paid-In Capital Chart

Laurus Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,947.70 7,013.20 7,130.60 7,170.80 -

Laurus Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,170.80 - - - -

Laurus Labs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Laurus Labs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs Headlines

No Headlines